| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 11.954 | 6.775 | 8.074 | 16.422 | 23.074 | 36.266 | 47.183 | 48.824 | 53.427 |
| Total Income - EUR | - | 11.954 | 6.775 | 8.074 | 16.422 | 23.074 | 36.266 | 47.183 | 48.824 | 53.427 |
| Total Expenses - EUR | - | 2.951 | 2.615 | 3.051 | 5.201 | 4.284 | 3.617 | 5.234 | 13.755 | 19.421 |
| Gross Profit/Loss - EUR | - | 9.002 | 4.161 | 5.023 | 11.221 | 18.790 | 32.650 | 41.949 | 35.069 | 34.007 |
| Net Profit/Loss - EUR | - | 8.644 | 3.958 | 4.780 | 10.729 | 18.142 | 31.583 | 40.800 | 34.581 | 32.404 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Cabinet Medical Nervasyst Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 704 | 512 | 325 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 8.375 | 12.346 | 17.775 | 11.947 | 19.503 | 31.919 | 41.063 | 46.165 | 33.920 |
| Inventories | - | 0 | 0 | 171 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 3.560 | 6.550 | 10.749 | 5.268 | 4.366 | 18.533 | 37.002 | 22.305 | 24.444 |
| Cash | - | 4.815 | 5.796 | 6.855 | 6.679 | 15.137 | 13.386 | 4.061 | 23.860 | 9.475 |
| Shareholders Funds | - | 8.688 | 12.499 | 17.050 | 10.779 | 18.192 | 31.632 | 40.849 | 44.912 | 32.452 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 391 | 359 | 1.051 | 1.168 | 1.312 | 287 | 215 | 1.253 | 1.468 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cabinet Medical Nervasyst Srl